Cy­ti­va opens doors at Cardiff site as part of $1.5B glob­al ex­pan­sion

In a Sep­tem­ber in­ter­view with End­points News, Cy­ti­va CMO Conor McK­ech­nie said that the com­pa­ny was fo­cus­ing on in-re­gion, for-re­gion man­u­fac­tur­ing as the bio­phar­ma world felt the im­pact of sup­ply woes that af­fect­ed the en­tire world.

How­ev­er, the com­pa­ny is now tak­ing its next step for­ward in sup­port­ing the glob­al in­dus­try with the open­ing of a new 118,400 square-foot site last week in Cardiff, Wales fo­cused on man­u­fac­tur­ing sin­gle-use bio­pro­cess­ing tech. Em­ploy­ees at the site have al­ready start­ed to make mix­er bags, flow kits and tub­ing as­sem­blies to ship to cus­tomers for the de­vel­op­ment of Covid-19 vac­cines, among oth­er bio­phar­ma­ceu­ti­cals. The site will ser­vice cus­tomers around the world, but pro­vide cus­tomers in the UK and Eu­rope with a clos­er op­er­a­tion to work along­side.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER